Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes

Autor: Jiancheng Ding, Hai-hua Huang, Hai-feng Shen, Jia Yi, Lei Wang, Guo-sheng Hu, Lan Wang, Ling-yun Lu, Fangqing Zhao, Wen Liu, Yue-ying Zhang, Yi-chen Liu
Rok vydání: 2021
Předmět:
Mice
Nude

Medicine (miscellaneous)
Estrogen receptor
Apoptosis
Breast Neoplasms
Cell Cycle Proteins
Biology
ER-positive breast cancer
medicine.disease_cause
Mice
03 medical and health sciences
0302 clinical medicine
Breast cancer
microRNA
Biomarkers
Tumor

Tumor Cells
Cultured

medicine
Animals
Humans
circRNA
Pharmacology
Toxicology and Pharmaceutics (miscellaneous)

miRNA
Cell Proliferation
030304 developmental biology
Mice
Inbred BALB C

0303 health sciences
Competing endogenous RNA
estrogen and estrogen receptor
Gene Expression Profiling
Cell Cycle
RNA
Estrogens
RNA
Circular

Cell cycle
Prognosis
medicine.disease
Xenograft Model Antitumor Assays
Cell Cycle Gene
Gene Expression Regulation
Neoplastic

Survival Rate
MicroRNAs
Receptors
Estrogen

Cancer research
Female
Receptors
Progesterone

Carcinogenesis
030217 neurology & neurosurgery
Research Paper
Zdroj: Theranostics
ISSN: 1838-7640
DOI: 10.7150/thno.45302
Popis: Estrogen and estrogen receptor (ER)-regulated gene transcriptional events have been well known to be involved in ER-positive breast carcinogenesis. Meanwhile, circular RNAs (circRNAs) are emerging as a new family of functional non-coding RNAs (ncRNAs) with implications in a variety of pathological processes, such as cancer. However, the estrogen-regulated circRNA program and the function of such program remain uncharacterized. Methods: CircRNA sequencing (circRNA-seq) was performed to identify circRNAs induced by estrogen, and cell proliferation, colony formation, wound healing, transwell and tumor xenograft experiments were applied to examine the function of estrogen-induced circRNA, circPGR. RNA sequencing (RNA-seq) and ceRNA network analysis wereperformed to identify circPGR's target genes and the microRNA (miRNA) bound to circPGR. Anti-sense oligonucleotide (ASO) was used to assess circPGR's effects on ER-positive breast cancer cell growth. Results: Genome-wide circRNA profiling by circRNA sequencing (circRNA-seq) revealed that a large number of circRNAs were induced by estrogen, and further functional screening for the several circRNAs originated from PGR revealed that one of them, which we named as circPGR, was required for ER-positive breast cancer cell growth and tumorigenesis. CircPGR was found to be localized in the cytosol of cells and functioned as a competing endogenous RNA (ceRNA) to sponge miR-301a-5p to regulate the expression of multiple cell cycle genes. The clinical relevance of circPGR was underscored by its high and specific expression in ER-positive breast cancer cell lines and clinical breast cancer tissue samples. Accordingly, anti-sense oligonucleotide (ASO) targeting circPGR was proven to be effective in suppressing ER-positive breast cancer cell growth. Conclusions: These findings reveled that, besides the well-known messenger RNA (mRNA), microRNA (miRNA), long non-coding RNA (lncRNA) and enhancer RNA (eRNA) programs, estrogen also induced a circRNA program, and exemplified by circPGR, these estrogen-induced circRNAs were required for ER-positive breast cancer cell growth, providing a new class of therapeutic targets for ER-positive breast cancer.
Databáze: OpenAIRE